Brad Stanard, MPH, PhD AstraZeneca

Dr. Stanard currently leads Occupational Toxicology and Product Quality as part of the Global Sustainability organization at AstraZeneca and previously held roles within the Environment, Health and Safety groups at Amgen and Amylin Pharmaceuticals. Dr. Stanard has over 18 years of experience in the biopharmaceutical industry covering a broad spectrum of responsibilities in the drug development process within R&D, clinical and commercial manufacturing operations. During this time, his primary focus has been on hazard identification and hazard/risk assessment, including occupational exposure limits and derivation of permitted daily exposure values for extractables and leachables, APIs, intermediates and impurities. Dr. Stanard received his PhD in toxicology from Colorado State University and an MPH in toxicology from San Diego State University.